期刊
JOURNAL OF BIOLOGICAL CHEMISTRY
卷 288, 期 26, 页码 18789-18802出版社
ELSEVIER
DOI: 10.1074/jbc.M112.420331
关键词
-
资金
- Wellcome Trust [077082]
- Agence Nationale pour la Recherche [ANR 2007 MIME-103-02]
- Fondation pour la Recherche Medicale [FRM allergy DAL 2007 0822007]
- Fond Europeen de Developpement Regional [FEDER Asthme 1575-32168]
- Le Studium Orleans, CNRS, Orleans, France
- British Biology Research Council [ALRJOD0]
- Natural Environment Research Council, UK
- Natural Environment Research Council [CEH010021] Funding Source: researchfish
Molecules that simultaneously inhibit independent or co-dependent proinflammatory pathways may have advantages over conventional monotherapeutics. OmCI is a bifunctional protein derived from blood-feeding ticks that specifically prevents complement (C)-mediated C5 activation and also sequesters leukotriene B4 (LTB4) within an internal binding pocket. Here, we examined the effect of LTB4 binding on OmCI structure and function and investigated the relative importance of C-mediated C5 activation and LTB4 in a mouse model of immune complex-induced acute lung injury (IC-ALI). We describe two crystal structures of bacterially expressed OmCI: one binding a C16 fatty acid and the other binding LTB4 (C20). We show that the C5 and LTB4 binding activities of the molecule are independent of each other and that OmCI is a potent inhibitor of experimental IC-ALI, equally dependent on both C5 inhibition and LTB4 binding for full activity. The data highlight the importance of LTB4 in IC-ALI and activation of C5 by the complement pathway C5 convertase rather than by non-C proteases. The findings suggest that dual inhibition of C5 and LTB4 may be useful for treatment of human immune complex-dependent diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据